HARBOR CAPITAL ADVISORS, INC.

Position in RGNX — REGENXBIO Inc.

CIK 1039128 CHICAGO, IL

Position in RGNX

as of Mar 31, 2026 · filed Apr 28, 2026 Compact

Position Value

$406,362

+$208,420 QoQ

Shares Held

48,492

+89.4% QoQ

Ownership

0.094%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

14 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HARBOR CAPITAL ADVISORS, INC. holds $23,126,231 across 27 Biotechnology names. RGNX ranks #15 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KYMR	Kymera Therapeutics, Inc.	33,948	$2,827,528
2	RYTM	Rhythm Pharmaceuticals, Inc.	30,353	$2,639,800
3	TARS	Tarsus Pharmaceuticals, Inc.	29,283	$2,054,202
4	VCEL	Vericel Corp	63,718	$2,049,808
5	HALO	Halozyme Therapeutics, Inc.	31,355	$2,026,473
6	RARE	Ultragenyx Pharmaceutical Inc.	83,196	$1,742,956
7	SRPT	Sarepta Therapeutics, Inc.	80,085	$1,742,649
8	AGIO	Agios Pharmaceuticals, Inc.	43,005	$1,454,859

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$406,362	48,492	+89.4%	Shares	Sole	2026-04-28
2024-12-31	$197,942	25,607	-29.0%	Shares	Sole	2025-01-10
2024-09-30	$378,500	36,082	+48.5%	Shares	Sole	2024-10-29
2024-06-30	$284,286	24,298	-55.5%	Shares	Sole	2024-07-09
2024-03-31	$1,150,443	54,601	+10.2%	Shares	Sole	2024-05-13
2023-12-31	$889,404	49,549	+2.0%	Shares	Sole	2024-01-08
2023-09-30	$799,281	48,559	+10.1%	Shares	Sole	2023-10-20
2023-06-30	$881,678	44,106	+81.7%	Shares	Sole	2023-07-11
2023-03-31	$459,059	24,276	-9.0%	Shares	Sole	2023-04-26
2022-12-31	$605,215	26,685	-2.1%	Shares	Sole	2023-01-20
2022-09-30	$720,455	27,259	-9.9%	Shares	Sole	2022-10-28
2022-06-30	$747,199	30,251	-6.8%	Shares	Sole	2022-07-26
2022-03-31	$1,077,347	32,460	-15.1%	Shares	Sole	2022-04-28
2021-12-31	$1,250,873	38,253	—	Shares	Sole	2022-02-04
No filing history on record for this holder in this stock.